NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews today reported a 258 percent rise year over year in third-quarter revenues.

Revenues in the quarter increased to C$157,692 (US$157,446) from C$43,999 as royalty revenues climbed to C$154,238, compared to none a year ago, the Toronto-based firm said in a document filed with Canadian Securities Administrators. Sales were down to C$3,454 from C$8,210, and milestone revenues dropped to zero from C$35,789 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.